Avricore Health Inc. operates in the healthcare sector, focusing on health data and point-of-care technologies, particularly through its HealthTab platform. While the company boasts a strong liquidity position with a current ratio of 8.24 and no debt, it faces significant challenges with a gross margin of only 1.9% and negative profitability metrics, including an EBITDA margin of -295.5%. This raises concerns about its operational efficiency and long-term sustainability. Overall, the low market cap of $5.69M relative to its financial struggles suggests potential undervaluation, but profitability remains a critical issue.
Loading financial metrics...
Company is burning $276K per quarter with $923K in cash. Approximately 3.3 quarters of runway at current burn rate.
Revenue fell 92.7% year-over-year from $2.6M to $193K. The decline has persisted for multiple quarters.
Company posted a loss of $-1.8M over the last year, representing 933.8% of revenue.
Operating cash flow has been negative for 3 consecutive quarters, burning $1.1M over the last year.
Debt-free balance sheet with a solid cash position, providing significant financial flexibility.
Excellent liquidity with current ratio of 8.2x ensures operational stability.
Low debt-to-revenue ratio of 0.0% indicates conservative financial management.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Diagnostics & Research companies of a similar size
Based on 2026-Q2 (June 30, 2026)